Wire Stories
-
382APO’s Newest Member Turkiye Hosts 64th Workshop Meeting of Heads of National Productivity Organizations
ANKARA, Turkiye–(BUSINESS WIRE)–#APO–Turkiye, the Asian Productivity Organization’s (APO’s) newest member, generously hosted the 64th Workshop Meeting (WSM) of Heads of National Productivity...
-
403Covation Holdings Continues Expansion in Asia Pacific With New Regional Corporate Headquarters
HONG KONG–(BUSINESS WIRE)–Covation Holdings Limited, the global manufacturer of multiple wheeled goods brands, today announced the addition of a new global corporate...
-
386Berkshire Hathaway Specialty Insurance Names Sami Jaghbir as Underwriting Manager in Queensland
BRISBANE, Australia & BOSTON–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has appointed Sami Jaghbir as Underwriting Manager, Queensland. “Sami...
-
494Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer
– Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy – – Enfortumab...
-
404Raludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
Encouraging overall response rate of 46% and disease control rate of 98% with a median duration of response of 11.2 months seen...
-
516Datopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan plus durvalumab showed a confirmed objective response rate of 79% Two ongoing phase 3 trials are...
-
475CHNT Group Showed at The 24th Conference on The Electric Power Supply Industry
XIAMEN, China–(BUSINESS WIRE)–On October 20th, the 24th Conference on The Electric Power Supply Industry kicked off in Xiamen, attended by more than...
-
798MakeMyTrip Limited to report Fiscal 2024 Second Quarter Financial & Operating Results on October 31, 2023
GURUGRAM, India & NEW YORK–(BUSINESS WIRE)–$MMYT #Fiscal2024–MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2024 second quarter financial and operating results...
-
500Foundation Medicine Expands Partnership with Sequanta to Provide both Liquid and Tissue Genomic Profiling Services in China to Support Global Regulatory Filings
Foundation Medicine will transfer FoundationOne®Liquid CDx technology to Sequanta in November 2023 and FoundationOne®CDx technology in March 2024 The partnership underscores Foundation...
-
370Samsung Electronics Holds Memory Tech Day 2023 Unveiling New Innovations To Lead the Hyperscale AI Era
Event spotlights next-generation memory solutions for applications such as cloud, edge devices and automotive vehicles New technologies and products include HBM3E Shinebolt,...
